The European Patent Office (EPO) has published patent application EP2026029135A1, titled 'AMYLOID ? ACCUMULATION MODEL ANIMAL', with a publication date of March 18, 2026. The application is classified under IPC codes C12N 5/071, A01K 67/0271, and C12Q 1/04. The designated states include a broad range of European countries.

This publication represents the disclosure of a new patent application related to animal models for studying amyloid accumulation, relevant to pharmaceutical and biotechnology research. As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, it is crucial for companies in the pharmaceutical and biotechnology sectors to monitor patent filings in their areas of research and development to understand the intellectual property landscape and potential future innovations or restrictions.